Two pharmaceutical companies, Pfizer and Sagent Pharmaceuticals, said the shortage is because of heightened demand and manufacturing delays. The other four drugmakers include Fresenius Kabi, Hikma Pharmaceuticals, Sky Pharma and Techdow USA.
As of Jan. 16, the heparin sodium solutions are back ordered until late January through March.
The shortage has been ongoing for months.
“[With] heparin flushes, we’re still having to use different products here at our health system than we normally want to,” Erin Fox, PharmD, the senior pharmacy director at Salt Lake City-based University of Utah Health who helps run ASHP’s drug shortage website, told Becker’s on Jan. 10.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
